UiPath (NYSE:PATH) CEO Sells $805,950.00 in Stock

UiPath, Inc. (NYSE:PATH) CEO Daniel Dines sold 45,000 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $17.91, for a total transaction of $805,950.00. Following the sale, the chief executive officer owned 29,018,585 shares of the company’s stock, valued at approximately $519,722,857.35. This trade represents a 0.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Daniel Dines also recently made the following trade(s):

• On Monday, December 15th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $17.30, for a total transaction of $778,500.00.
• On Wednesday, December 10th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $18.61, for a total value of $837,450.00.
• On Monday, December 8th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $19.21, for a total value of $864,450.00.
• On Wednesday, November 5th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $15.07, for a total value of $678,150.00.
• On Monday, November 3rd, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.23, for a total value of $730,350.00.
• On Friday, October 31st, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $15.72, for a total value of $707,400.00.
• On Wednesday, October 29th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.29, for a total transaction of $733,050.00.
• On Monday, October 27th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.73, for a total transaction of $752,850.00.
• On Friday, October 24th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $15.46, for a total transaction of $695,700.00.
• On Wednesday, October 22nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $15.53, for a total transaction of $698,850.00.

UiPath Price Performance

Shares of PATH stock traded down $1.30 on Monday, reaching $16.13. 23,709,137 shares of the company were exchanged, compared to its average volume of 15,560,561. The company has a 50-day moving average of $15.48 and a 200-day moving average of $13.29. The company has a market cap of $8.62 billion, a price-to-earnings ratio of 38.39, a PEG ratio of 5.19 and a beta of 1.10. UiPath, Inc. has a one year low of $9.38 and a one year high of $19.84.

UiPath (NYSE:PATH) last issued its earnings results on Wednesday, December 3rd. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.02. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The business had revenue of $411.11 million during the quarter, compared to analyst estimates of $392.46 million. During the same period in the previous year, the company posted $0.11 EPS. The firm’s revenue was up 15.9% compared to the same quarter last year. As a group, sell-side analysts predict that UiPath, Inc. will post -0.17 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on PATH shares. Weiss Ratings raised shares of UiPath from a “sell (d+)” rating to a “hold (c)” rating in a research report on Tuesday, December 9th. Cowen restated a “hold” rating on shares of UiPath in a report on Thursday, December 4th. Barclays lifted their price target on UiPath from $14.00 to $16.00 and gave the company an “equal weight” rating in a research note on Thursday, December 4th. UBS Group reissued a “neutral” rating on shares of UiPath in a report on Thursday, December 4th. Finally, Canaccord Genuity Group lifted their target price on UiPath from $15.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, December 4th. One investment analyst has rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $16.00.

Institutional Trading of UiPath

A number of institutional investors and hedge funds have recently modified their holdings of PATH. PNC Financial Services Group Inc. grew its stake in UiPath by 30.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 16,590 shares of the company’s stock valued at $171,000 after purchasing an additional 3,873 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of UiPath by 6.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,995,632 shares of the company’s stock worth $30,855,000 after purchasing an additional 177,071 shares during the last quarter. National Bank of Canada FI purchased a new position in UiPath in the first quarter valued at approximately $72,000. Invesco Ltd. increased its position in UiPath by 18.8% in the first quarter. Invesco Ltd. now owns 454,849 shares of the company’s stock worth $4,685,000 after buying an additional 72,049 shares during the last quarter. Finally, Nuveen LLC bought a new stake in shares of UiPath in the first quarter valued at $10,503,000. 62.50% of the stock is owned by hedge funds and other institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.